9th Annual Association for Bariatric Endoscopy (ABE) Meeting | May 2024 ABEAM2024-Medications for Patients with MASLD/MASH + Panel Discussion

Medications for Patients with MASLD/MASH + Panel Discussion

Pdf Summary

This document presents a case of a 37-year-old male with ALT-predominant liver enzyme elevation and underlying health issues like obesity, sleep apnea, and diabetes. The patient had liver abnormalities on imaging and biopsy consistent with steatohepatitis. Initial management focused on weight loss through lifestyle modifications, addressing cardiovascular risk factors, abstaining from alcohol, and medication review. If conservative measures fail, options like bariatric procedures and pharmacotherapy are considered. The document poses clinical questions on managing steatohepatitis, introducing pharmacological therapies, and their efficacy. References are provided for further reading on potential treatments like resmetirom and glucagon-like peptide-1 receptor agonists. The comprehensive approach emphasizes lifestyle changes as first-line treatment with medical interventions as alternatives if necessary.

Asset Subtitle

Adam Jacob, DO

Keywords

liver enzyme elevation

steatohepatitis

ALT-predominant

obesity

sleep apnea

diabetes

weight loss

bariatric procedures

pharmacotherapy

pharmacological therapies